Translating Research Into Practice

Review of a Study of Duloxetine for Painful Chemotherapy-Induced Peripheral Neuropathy

Rita Wickham, PhD, RN, AOCN®

Independent Oncology and Palliative Care Consultant

The author has no conflicts of interest to disclose.

Correspondence to: Rita Wickham, PhD, RN, AOCN®. E-mail: rita_wickham@yahoo.com


J Adv Pract Oncol 2013;4:361–368 | DOI: 10.6004/jadpro.2013.4.5.8 | © 2013 Harborside Press®


  

ABSTRACT

In a recent issue of JAMA, Smith et al. evaluated the use of duloxetine in the treatment of patients with painful chemotherapy-induced peripheral neuropathy (CIPN). Here, JADPRO contributors give an overview of the Smith study and offer a researcher’s perspective on the challenges associated with studying CIPN.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here